Semaglutide B, 1.34 mg/mL

DRUG2 trials

Sponsors

Novo Nordisk A/S

Conditions

Diabetes Mellitus, Type 2Healthy ParticipantsHealthy Volunteers (Diabetes Mellitus, Type 2)

Phase 1

A Clinical Trial Looking at the Comparability of 2 Different Forms of Semaglutide

CompletedNCT05232708

Novo Nordisk A/SHealthy Volunteers (Diabetes Mellitus, Type 2)

Start: 2022-01-19End: 2022-08-30Updated: 2024-01-26

A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose

CompletedNCT05689099

Novo Nordisk A/SDiabetes Mellitus, Type 2, Healthy Participants

Start: 2023-01-17End: 2023-05-30Updated: 2024-10-15